• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Colleen M. Feltmate, MD


  • Worley MJ, Guseh SH, Rauh-Hain JA, Esselen KM, Muto MG, Feltmate CM, Berkowitz RS, Del Carmen MG, Schorge JO, Horowitz NS.What is the optimal treatment for obese patients with advanced ovarian carcinoma?.Am J Obstet Gynecol. 2014 Apr 1.
  • Viswanathan AN, Lee H, Berkowitz R, Berlin S, Campos S, Feltmate C, Horowitz N, Muto M, Sadow CA, Matulonis U.A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer.Gynecol Oncol. 2014 Jan;132(1):55-60.
  • Worley MJ, Guseh SH, Rauh-Hain JA, Williams KA, Muto MG, Feltmate CM, Berkowitz RS, Horowitz NS.Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery?.Gynecol Oncol. 2013 Apr;129(1):69-73.
  • Worley MJ, Nitschmann CC, Shoni M, Rauh-Hain JA, Williams KA, Feltmate CM.Preoperative leukocytosis imposes an increased risk of recurrence and death among patients with nonendometrioid endometrial carcinoma.Int J Gynecol Cancer. 2013 Feb;23(2):312-7.
  • Shoni M, Parra-Herran CE, May T, Wright AA, Feltmate CM.Multiple synchronous primary gynecologic malignancies in an MSH2 mutation carrier with endometriosis.J Clin Oncol. 2013 Jan 20;31(3):e33-6.
  • Growdon WB, Wolfberg AJ, Goldstein DP, Feltmate CM, Chinchilla ME, Lieberman ES, Berkowitz RS.Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.J Reprod Med.;55(7-8):279-84.
  • Folkins AK, Nevadunsky NS, Saleemuddin A, Jarboe EA, Muto MG, Feltmate CM, Crum CP, Hirsch MS.Evaluation of vascular space involvement in endometrial adenocarcinomas: laparoscopic vs abdominal hysterectomies.Mod Pathol. 2010 Aug;23(8):1073-9.
  • Chang MC, Nevadunsky NS, Viswanathan AN, Crum CP, Feltmate CM.Endocervical adenocarcinoma in situ with ovarian metastases: a unique variant with potential for long-term survival.Int J Gynecol Pathol. 2010 Jan;29(1):88-92.
  • Growdon WB,Wolfberg AJ,Goldstein DP,Feltmate CM,Chinchilla ME,Lieberman ES,Berkowitz RS.Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.Gynecol Oncol. 2009 Feb;112(2):353-7.
  • Ko EM,Muto MG,Berkowitz RS,Feltmate CM.Robotic versus open radical hysterectomy: a comparative study at a single institution.Gynecol Oncol. 2008 Dec;111(3):425-30.
  • Garrett LA,Garner EI,Feltmate CM,Goldstein DP,Berkowitz RS.Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia.J Reprod Med. 2008 Jul;53(7):481-6.
  • Callahan MJ, Crum CP, Medeiros F, Kindelberger DW, Elvin JA, Garber JE, Feltmate CM, Berkowitz RS, Muto MG.Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.J Clin Oncol. 2007 Sep 1;25(25):3985-90.
  • Garner EI, Goldstein DP, Feltmate CM, Berkowitz RS.Gestational trophoblastic disease.Clin Obstet Gynecol. 2007 Mar;50(1):112-22. Review.
  • Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C, Berkowitz RS, Muto MG, Crum CP.Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.Am J Surg Pathol. 2007 Feb;31(2):161-9.
  • Feltmate CM, Growdon WB, Wolfberg AJ, Goldstein DP, Genest DR, Chinchilla ME, Lieberman ES, Berkowitz RS.Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.J Reprod Med. 2006 Nov;51(11):902-6.
  • Growdon WB, Wolfberg AJ, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES.Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.J Reprod Med. 2006 Nov;51(11):871-4.
  • Wolfberg AJ, Growdon WB, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES.Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.Obstet Gynecol. 2006 Aug;108(2):393-6.
  • Wamunyokoli FW, Bonome T, Lee JY, Feltmate CM, Welch WR, Radonovich M, Pise-Masison C, Brady J, Hao K, Berkowitz RS, Mok S, Birrer MJ.Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance.Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):690-700.
  • Feltmate CM, Lee KR, Johnson M, Schorge JO, Wong KK, Hao K, Welch WR, Bell DA, Berkowitz RS, Mok SC.Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.Clin Cancer Res. 2005 Nov 1;11(21):7651-7.
  • Garner EI, Feltmate CM, Goldstein DP, Berkowitz RS.The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey.Gynecol Oncol. 2005 Oct;99(1):3-5.
  • Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E.Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.Obstet Gynecol. 2005 Sep;106(3):548-52.
  • Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E.Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.Obstet Gynecol. 2004 Sep;104(3):551-4.
  • Feltmate CM, Batorfi J, Fulop V, Goldstein DP, Doszpod J, Berkowitz RS.Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation.Obstet Gynecol. 2003 Apr;101(4):732-6.
  • Feltmate CM, Genest DR, Goldstein DP, Berkowitz RS.Advances in the understanding of placental site trophoblastic tumor.J Reprod Med. 2002 May;47(5):337-41.
  • Kim JH, Skates SJ, Uede T, Wong Kk KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, Mok SC.Osteopontin as a potential diagnostic biomarker for ovarian cancer.JAMA. 2002 Apr 3;287(13):1671-9.
  • Feltmate CM, Genest DR, Wise L, Bernstein MR, Goldstein DP, Berkowitz RS.Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center.Gynecol Oncol. 2001 Sep;82(3):415-9.
  • Feltmate CM, Duska LR, Chang Y, Flynn CE, Nikrui N, Kiggundu E, Goodman A, Fuller AF, McIntyre JF.Predictors of recurrence in surgical stage II endometrial adenocarcinoma.Gynecol Oncol. 1999 Jun;73(3):407-11.
  • Rao PM, Feltmate CM, Rhea JT, Schulick AH, Novelline RA.Helical computed tomography in differentiating appendicitis and acute gynecologic conditions.Obstet Gynecol. 1999 Mar;93(3):417-21.
  • Ginsburg ES, Walsh BW, Gao X, Gleason RE, Feltmate C, Barbieri RL.The effect of acute ethanol ingestion on estrogen levels in postmenopausal women using transdermal estradiol.J Soc Gynecol Investig. 1995 Jan-Feb;2(1):26-9.
  • Ginsburg ES, Walsh BW, Shea BF, Gao X, Gleason RE, Feltmate C, Barbieri RL.Effect of acute ethanol ingestion on prolactin in menopausal women using estradiol replacement.Gynecol Obstet Invest. 1995;39(1):47-9.